HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES HDAC INHIBITORS AS CANDIDATE THERAPEUTICS FOR MYC-DRIVEN MEDULLOBLASTOMA

BACKGROUND: Medulloblastoma (MB) is a highly malignant pediatric brain tumor. Despite aggressive therapy, many patients succumb to the disease, and survivors experience severe side effects from treatment. MBs with high levels of the MYC oncogene have a particularly poor prognosis, and would benefit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Wechsler-Reya, Robert J., Pei, Yanxin, Liu, Kun-Wei, Wang, Jun, Esparza, Lourdes A., Maier, Donna L., Li, Xiao-Nan, Cho, Yoon-Jae
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144567/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.22
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items